Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...

Eli Lilly (LLY) emerges among the top performers in Big Pharma in 2024 with obesity drug success, while Novo Nordisk (NVO) ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...

Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...

EUROPE’S Stoxx 600 index clocked its first weekly advance in three on Friday (Dec 27), boosted by advancing healthcare and ...

Tmall's shopping list for the pharmaceutical platform on Double Eleven! The transaction volume exceeded 100 million in just 2 minutes ...

live cricket score india and australia Innovent Biologics Obtains Exclusive Rights to Two Cell Immunotherapy Products in Mainland China, Hong Kong and Macau Novo Nordisk Q1 2020: China grew 13%, ...

From politics to pop culture, climate to conflict, 2024 was a year of tumbling records … but not always for the best reasons.

INR:9310. danske spil oddset regler 『Pharmaceutical Headlines』CD147 antibody clinical trial data released, epidemic makes disinfectant popular Chine ...

INR:0330. ace 2 three plus 4 Novo Nordisk's Fiasp is approved in Canada for use in pediatric patients aged ≥ 2 years! After much anticipation, this new breas ...